FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39198411000001107: Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Jan 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
149061000001114 Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
149071000001116 Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Is a Tezacaftor 50mg / Ivacaftor 75mg tablets true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Is a Symkevi true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has specific active ingredient Tezacaftor true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has specific active ingredient Ivacaftor true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets Has AMP True Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start